Tel Aviv, Israel

Yaron Daniely

This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Alcobra Ltd., Vallon Pharmaceuticals, Inc.. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yaron Daniely. Retrieved from https://idiyas.com/inventor/yaron-daniely

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yaron Daniely

Introduction: Yaron Daniely, a visionary inventor hailing from Tel Aviv, Israel, has made significant contributions to the world of technology and innovation.

Latest Patents: Yaron Daniely holds several groundbreaking patents in the fields of biotechnology, artificial intelligence, and renewable energy, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Yaron Daniely has led numerous successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Yaron Daniely has collaborated with top research institutions, leading companies, and brilliant minds from around the globe, fostering a culture of innovation and excellence.

Conclusion: Yaron Daniely's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His impact will continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…